Delivery Order SPE2DB22D2007-SPE2DB24FJ5SM
Award Date
9/3/24
Potential Completion Date
9/24/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, involves the delivery of IMBRUVICA 140 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The firm fixed price delivery order, valued at $23,537.16, has an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of IMBRUVICA 280 MG TABLET 28S. The $15,151.52 firm fixed-price contract has a completion date of July 8, 2025 and is not a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a wide range of pharmaceutical products and...
This is a $8,116.87 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product, with a performance period ending on June 12, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $16,233.74, is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a prescription medication. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 15, 2025. The contract is not set aside for any specific business type. AmerisourceBergen holds...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of IMBRUVICA 420 MG TABLET 28S. The award, valued at $7,575.75, is a firm fixed-price contract with a completion date of December 26, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $7,845.72, is for the delivery of Imbruvica 140 mg capsules over a period ending on March 20, 2024. AmerisourceBergen Drug Corp, as the prime contractor, will supply this pharmaceutical product to support military treatment programs and facilities....
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $7,845.72 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. This delivery order is for the supply of IMBRUVICA 140 MG CAPSULE 90S, a specialty pharmaceutical product, with a completion date of February 21, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division, serves as the prime contractor on this...
Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded a $7,322.67 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide IMBRUVICA 420 MG TABLET 28S. This order is a part of Amerisourcebergen's larger indefinite delivery contract (IDC) with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC, which does not have a set-aside designation,...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMBRUVICA 140 MG CAPSULE 90S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and a ceiling value of $8,116.87. The contract is not set aside for any specific type of business. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $7,575.75 firm-fixed-price contract is for the delivery of IMBRUVICA 420 MG TABLET 28S, a medication. The contract has a period of performance through June 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global...